Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Cao, J ^a   Wang, J ^a   Dwyer, J B ^b   Gautier, N M ^a   Wang, S ^a   Leslie, F M ^b   Li, M D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescence; Gestation; Myelin; Nicotine; Oligodendrocyte; Smoking

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CHONDROITIN SULFATE PROTEOGLYCAN 4; CLAUDIN 11; CONNEXIN 47; GALACTOSYLCERAMIDASE; GAP JUNCTION MEMBRANE CHANNEL PROTEIN EPSILON 1; GAP JUNCTION PROTEIN BETA 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOSYLTRANSFERASE 8; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; MESSENGER RNA; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NICOTINE; PROTEIN; PROTEOLIPID PROTEIN 1; T CELL DIFFERENTIATION PROTEIN; UNCLASSIFIED DRUG; MBP PROTEIN, RAT; MYELIN BASIC PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENCE; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; MALE; MYELINATION; NONHUMAN; NUCLEUS ACCUMBENS; OLIGODENDROGLIA; ONSET AGE; PERINATAL PERIOD; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PROGENY; PROTEIN EXPRESSION; PUTAMEN; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WESTERN BLOTTING; ANIMAL; BRAIN; BRAIN CHEMISTRY; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; METABOLISM; MYELIN SHEATH; MYELINATED NERVE; PREGNANCY; SPRAGUE DAWLEY RAT; BRAIN LEVEL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; FEMALE; GENE EXPRESSION; MALE; MYELIN BASIC PROTEIN; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NICOTINE; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 84878630351     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.21     Document Type: Article

References (59)

1. Knopik VS. Maternal smoking during pregnancy and child outcomes: real or spurious effect? Dev Neuropsychol 2009; 34: 1-36.
2. Weissman MM, Warner V, Wickramaratne PJ, Kandel DB. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry 1999; 38: 892-899. (Pubitemid 29309850)
3. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463. (Pubitemid 30243061)
4. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 2008; 9: 947-957.
5. Cao J, Dwyer JB, Mangold JE, Wang J, Wei J, Leslie FM et al. Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int J Neuropsychopharmacol 2011; 14: 157-174.
6. Wei J,Wang J, Dwyer JB, Mangold J, Cao J, Leslie FM et al. Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol 2011; 14: 91-106.
7. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81: 871-927. (Pubitemid 32267079)
8. Bora E, Yucel M, Fornito A, Pantelis C, Harrison BJ, Cocchi L et al. White matter microstructure in opiate addiction. Addict Biol 2012; 17: 141-148.
9. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008; 31: 361-370.
10. Bartzokis G. Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front Biosci 2012; 17: 2695-2733.
11. Eschenroeder AC, Vestal-Laborde AA, Sanchez ES, Robinson SE, Sato-Bigbee C. Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of mu-opioid-and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy. Glia 2012; 60: 125-136.
12. Hursh JB. Conduction velocity and diameter of nerve fiber. Am Physiol Soc 1939; 127: 131-139.
13. Du Y, Dreyfus CF. Oligodendrocytes as providers of growth factors. J Neurosci Res 2002; 68: 647-654. (Pubitemid 34594982)
14. Nave KA, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 2008; 31: 535-561.
15. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM et al. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA 2007; 104: 8131-8136. (Pubitemid 47185887)
16. Belachew S, Rogister B, Rigo JM, Malgrange B, Moonen G. Neurotransmitter-mediated regulation of CNS myelination: a review. Acta Neurol Belg 1999; 99: 21-31. (Pubitemid 29171837)
17. Laursen LS, Ffrench-Constant C. Adhesion molecules in the regulation of CNS myelination. Neuron Glia Biol 2007; 3: 367-375. (Pubitemid 351944156)
18. Melli G, Hoke A. Canadian Association of Neurosciences review: regulation of myelination by trophic factors and neuron-glial signaling. Can J Neurol Sci 2007; 34: 288-295. (Pubitemid 47359831)
19. Kafitz KW, Herth G, Bartsch U, Guttinger HR, Schachner M. Application of testosterone accelerates oligodendrocyte maturation in brains of zebra finches. Neuroreport 1992; 3: 315-318.
20. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007; 116: 77-106. (Pubitemid 47398920)
21. Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J Neurosci 2006; 26: 1439-1447. (Pubitemid 43237014)
22. Perrin JS, Herve PY, Leonard G, Perron M, Pike GB, Pitiot A et al. Growth of white matter in the adolescent brain: role of testosterone and androgen receptor. J Neurosci 2008; 28: 9519-9524.
23. Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines production -the possible cause of gender differences in neurological diseases. Curr Pharm Des 2005; 11: 1017-1030. (Pubitemid 40331302)
24. Lin F, Wu G, Zhu L, Lei H. Heavy smokers show abnormal microstructural integrity in the anterior corpus callosum: A diffusion tensor imaging study with tract-based spatial statistics. Drug Alcohol Depend 2012; 129: 82-87.
25. Kim JK, Choi JW, Lim S, Kwon O, Seo JK, Ryu SH et al. Phospholipase C-eta1 is activated by intracellular Ca(2) mobilization and enhances GPCRs/PLC/Ca(2) signaling. Cell Signal 2011; 23: 1022-1029.
26. Park MK, Loughlin SE, Leslie FM. Gestational nicotine-induced changes in adolescent neuronal activity. Brain Res 2006; 1094: 119-126. (Pubitemid 43927619)
27. Matta SG, Elberger AJ. Combined exposure to nicotine and ethanol throughout full gestation results in enhanced acquisition of nicotine self-administration in young adult rat offspring. Psychopharmacology 2007; 193: 199-213. (Pubitemid 47025019)
28. Franke RM, Belluzzi JD, Leslie FM. Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats. Psychopharmacology 2007; 195: 117-124. (Pubitemid 47568624)
29. Paxinos G, Watson C, 2005The Rat Brain in Stereotxic Coordinates. Academic Press Inc.: San Diego.
30. Wegner M. A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 2008; 35: 3-12.
31. Gutala R, Wang J, Kadapakkam S, Hwang Y, Ticku M, Li MD. Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitinproteasome pathway and protein synthesis. Alcohol Clin Exp Res 2004; 28: 1779-1788. (Pubitemid 39665193)
32. Li MD, Kane JK, Wang J, Ma JZ. Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res Mol Brain Res 2004; 132: 168-180. (Pubitemid 39586759)
33. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999; 270: 41-49. (Pubitemid 29230718)
34. Readhead C, Takasashi N, Shine HD, Saavedra R, Sidman R, Hood L. Role of myelin basic protein in the formation of central nervous system myelin. Ann NY Acad Sci 1990; 605: 280-285.
35. Carre JL, Goetz BD, O'Connor LT, Bremer Q, Duncan ID. Mutations in the rat myelin basic protein gene are associated with specific alterations in other myelin gene expression. Neurosci Lett 2002; 330: 17-20. (Pubitemid 35245759)
36. Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther 2009; 122: 125-139.
37. Pauly JR, Slotkin TA. Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr 2008; 97: 1331-1337.
38. Sokolov BP. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol 2007; 10: 547-555. (Pubitemid 46985259)
39. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. Connexins are critical for normal myelination in the CNS. J Neurosci 2003; 23: 5963-5973. (Pubitemid 36807876)
40. Chang L, Cloak CC, Jiang CS, Hoo A, Hernandez AB, Ernst TM. Lower glial metabolite levels in brains of young children with prenatal nicotine exposure. J Neuroimmune Pharmacol 2012; 7: 243-252.
41. Matsuoka T, Sumiyoshi T, Tsunoda M, Takasaki I, Tabuchi Y, Uehara T et al. Change in the expression of myelination/oligodendrocyte-related genes during puberty in the rat brain. J Neural Transm 2010; 117: 1265-1268.
42. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213: 93-118.
43. Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol 2008; 154: 261-274. (Pubitemid 351670601)
44. Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Kirkham D et al. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia 2007; 55: 341-351.
45. Anderson TJ, Klugmann M, Thomson CE, Schneider A, Readhead C, Nave KA et al. Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication. Ann NY Acad Sci 1999; 883: 234-246. (Pubitemid 129495432)
46. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B, Braun PE. Overexpression of 20,30-cyclic nucleotide 30-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 1996; 7: 453-466. (Pubitemid 26300332)
47. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J Neurosci Res 1997; 50: 238-247. (Pubitemid 27473639)
48. Quaranta L, Sabatelli M, Madia F, Ricci E, Lippi G, Conte A et al. Expanding the nosology of hypermyeliating neuropathies: description of two new entities. J Peripheral Nervous Syst 2002; 7: 82-83.
49. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000; 157: 816-818. (Pubitemid 30249663)
50. Peterson BS. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J Clin Psychiatry 1996; 57(Suppl 9): 24-34. (Pubitemid 26327754)
51. Wolraich ML, Wibbelsman CJ, Brown TE, Evans SW, Gotlieb EM, Knight JR et al. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics 2005; 115: 1734-1746. (Pubitemid 43843185)
52. Rogers SW, Gregori NZ, Carlson N, Gahring LC, Noble M. Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia 2001; 33: 306-313. (Pubitemid 32285747)
53. Stocker S, Guttinger HR, Herth G. Exogenous testosterone differentially affects myelination and neurone soma sizes in the brain of canaries. Neuroreport 1994; 5: 1449-1452. (Pubitemid 24251869)
54. Wang Y, Adamson C, Yuan W, Altaye M, Rajagopal A, Byars AW et al. Sex differences in white matter development during adolescence: a DTI study. Brain Res 2012; 1478: 1-15.
55. Meyer DC, Carr LA. The effects of perinatal exposure to nicotine on plasma LH levels in prepubertal rats. Neurotoxicol Teratol 1987; 9: 95-98. (Pubitemid 17119880)
56. Fried PA, James DS, Watkinson B. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2001; 23: 431-436. (Pubitemid 33044559)
57. Colello RJ, Pott U. Signals that initiate myelination in the developing mammalian nervous system. Mol Neurobiol 1997; 15: 83-100. (Pubitemid 127719574)
58. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor Jr. Oligodendrocytes and myelination: the role of iron. Glia 2009; 57: 467-478.
59. de Arriba Zerpa GA, Saleh MC, Fernandez PM, Guillou F, Espinosa de los Monteros A, de Vellis J et al. Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line. J Neurosci Res 2000; 61: 388-395. (Pubitemid 30620224)